RE:RE:Volume versus increase in share price - "don't like it"floatinketucky wrote: ISSUER: Theralase Technologies Inc. Principal Jurisdiction - Ontario DATES: Preliminary Shelf Prospectus (NI 44-102) dated July 30, 2018 Closed on December 18, 2018 PROJECT NUMBER: 2800145 TLT is unable to do a PP the the procpectus closed. Do you agree? SouthernTierTom How does this fit into your ideal? "
A LOT of people are cashing in their shares at this level I STILL maintain there will be a cheaper financing that will benefit those getting out at this level that are "privileged" to get PP paper with warrants. Way too bullboard program from our pals. "
They wouldn't do a PP under the shelf prospectus plan but why couldn't they do a regular PP which is structured a little differently or for that matter a brokered deal which has the same dilutive effect for shareholders?
Isn't it unusual to have the OSC make the shelf prospectus termination disclosure with no word from TLT as to the reason why such action was taken? One would think they could have kept the shelf prospectus in place and still seek a JV with a strategic partner. I don't see how the two would conflict.